Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

496 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial.
Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefèbvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Korányi L, Laakso M, Mokán M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J; PROactive Investigators. Dormandy JA, et al. Among authors: smith u. Lancet. 2005 Oct 8;366(9493):1279-89. doi: 10.1016/S0140-6736(05)67528-9. Lancet. 2005. PMID: 16214598 Free article. Clinical Trial.
Exenatide improves β-cell function up to 3 years of treatment in patients with type 2 diabetes: a randomised controlled trial.
van Raalte DH, Bunck MC, Smits MM, Hoekstra T, Cornér A, Diamant M, Eliasson B, Marja-RiittaTaskinen, Heine RJ, Smith U, HanneleYki-Järvinen, Mari A. van Raalte DH, et al. Among authors: smith u. Eur J Endocrinol. 2016 Oct;175(4):345-52. doi: 10.1530/EJE-16-0286. Epub 2016 Jul 27. Eur J Endocrinol. 2016. PMID: 27466218 Clinical Trial.
Visfatin is an adipokine, but it is not regulated by thiazolidinediones.
Hammarstedt A, Pihlajamäki J, Rotter Sopasakis V, Gogg S, Jansson PA, Laakso M, Smith U. Hammarstedt A, et al. Among authors: smith u. J Clin Endocrinol Metab. 2006 Mar;91(3):1181-4. doi: 10.1210/jc.2005-1395. Epub 2006 Jan 4. J Clin Endocrinol Metab. 2006. PMID: 16394088
One-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trial.
Bunck MC, Diamant M, Cornér A, Eliasson B, Malloy JL, Shaginian RM, Deng W, Kendall DM, Taskinen MR, Smith U, Yki-Järvinen H, Heine RJ. Bunck MC, et al. Among authors: smith u. Diabetes Care. 2009 May;32(5):762-8. doi: 10.2337/dc08-1797. Epub 2009 Feb 5. Diabetes Care. 2009. PMID: 19196887 Free PMC article. Clinical Trial.
Linking diabetes and cancer: a consensus on complexity.
Renehan A, Smith U, Kirkman MS. Renehan A, et al. Among authors: smith u. Lancet. 2010 Jun 26;375(9733):2201-2. doi: 10.1016/S0140-6736(10)60706-4. Lancet. 2010. PMID: 20609959 No abstract available.
496 results